Why the first 90 days matter most
The early weeks of GLP-1 treatment are when support between visits can matter most.
The first 90 days of GLP-1 therapy are an important adjustment period. Patients are learning how their body responds, navigating side effects, and translating clinical guidance into daily life around food, hydration, movement, and treatment routines.
This is also a period when uncertainty, side effects, access barriers, and everyday circumstances can contribute to treatment interruption or discontinuation.
Koa is designed to stay with patients between visits, build longitudinal understanding of the individual, recognize meaningful changes, and support appropriate handoff back to the care team when human intervention is needed.
Designed to support appropriate GLP-1 persistence while keeping clinical decisions with the treating care team.
.png)
NuVee 2026
Tools that help patients take control of their health
Tools that help patients take control of their health
NuVee builds digital health tools designed to support patients alongside their clinical care.
NuVee does not provide medical advice or replace licensed healthcare professionals.
NuVee does not provide medical advice or replace licensed healthcare professionals.